A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinoma

Tomohiro Fukui(Kyoto University), Shusuke Akamatsu(Kyoto University)

Cancer Medicine

February 27, 2025

10.1002/cam4.70047

Cited by 1

Related Papers

Association of a novel long non‐coding RNA in <i>8q24</i> with prostate cancer susceptibility

|Cancer Science|2010|286

Prostate cancer genomics, biology, and risk assessment through genome‐wide association studies

|Cancer Science|2011|37

Extracellular vesicles secreted from bone metastatic renal cell carcinoma promote angiogenesis and endothelial gap formation in bone marrow in a time-dependent manner in a preclinical mouse model

|Frontiers in Oncology|2023|7

Case Report: Genomic insights into prostate adenocarcinoma transdifferentiation to carcinosarcoma due to lineage plasticity

|Frontiers in Oncology|2025|0